BVP
MDT icon

Bristlecone Value Partners’s Medtronic MDT Stock Holding History

Bristlecone Value Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Hold
4,060
– – 0.26% 61
2026
Q1 		$352K Buy
+4,060
New +$389K 0.31% 55

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bristlecone Value Partners's MDT Position: Q2 2026 in Review

Bristlecone Value Partners held its Medtronic (MDT) position steady in Q2 2026 at 4,060 shares worth $318K. The position accounts for 0.26% of the portfolio, ranked #61.

Bristlecone Value Partners first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. The position peaked at $352K in Q1 2026. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bristlecone Value Partners held 4,060 shares of Medtronic worth $318K as of Q2 2026.
  • Bristlecone Value Partners left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.26% of Bristlecone Value Partners's portfolio in Q2 2026, its #61 holding.
  • Bristlecone Value Partners first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
  • Bristlecone Value Partners's Medtronic position peaked at $352K in Q1 2026.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bristlecone Value Partners's 13F filing for Q2 2026, filed 14 Aug 2026.